IRIS Accounts Production v25.1.3.33 00755431 Board of Directors 1.2.24 31.1.25 31.1.25 true false true false false true false Fair value model 77 77 77 77 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh007554312024-01-31007554312025-01-31007554312024-02-012025-01-31007554312023-01-31007554312023-02-012024-01-31007554312024-01-3100755431ns15:EnglandWales2024-02-012025-01-3100755431ns14:PoundSterling2024-02-012025-01-3100755431ns10:Director12024-02-012025-01-3100755431ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3100755431ns10:SmallEntities2024-02-012025-01-3100755431ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3100755431ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-3100755431ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-3100755431ns10:FullAccounts2024-02-012025-01-3100755431ns10:Director2422024-01-3100755431ns10:Director2422023-02-012024-01-3100755431ns10:Director2422024-02-012025-01-3100755431ns10:Director2422024-01-3100755431ns10:Director22024-02-012025-01-3100755431ns10:CompanySecretary12024-02-012025-01-3100755431ns10:RegisteredOffice2024-02-012025-01-3100755431ns5:CurrentFinancialInstruments2025-01-3100755431ns5:CurrentFinancialInstruments2024-01-3100755431ns5:Non-currentFinancialInstruments2025-01-3100755431ns5:Non-currentFinancialInstruments2024-01-3100755431ns5:ShareCapital2025-01-3100755431ns5:ShareCapital2024-01-3100755431ns5:CapitalRedemptionReserve2025-01-3100755431ns5:CapitalRedemptionReserve2024-01-3100755431ns5:RetainedEarningsAccumulatedLosses2025-01-3100755431ns5:RetainedEarningsAccumulatedLosses2024-01-3100755431ns5:FurnitureFittings2024-02-012025-01-3100755431ns5:FurnitureFittings2025-01-3100755431ns5:UnlistedNon-exchangeTradedns5:CostValuation2024-01-3100755431ns5:UnlistedNon-exchangeTradedns5:DisposalsRepaymentsInvestments2025-01-3100755431ns5:UnlistedNon-exchangeTradedns5:CostValuation2025-01-3100755431ns5:UnlistedNon-exchangeTraded2025-01-3100755431ns5:UnlistedNon-exchangeTraded2024-01-3100755431ns5:Subsidiary12024-02-012025-01-31007554311ns5:Subsidiary12024-02-012025-01-3100755431ns5:Subsidiary12025-01-3100755431ns5:Subsidiary12024-01-3100755431ns5:Subsidiary12023-02-012024-01-3100755431ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3100755431ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3100755431ns5:CurrentFinancialInstruments2024-02-012025-01-3100755431ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2025-01-3100755431ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-01-3100755431ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-01-3100755431ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-01-3100755431ns5:Secured2025-01-3100755431ns5:Secured2024-01-3100755431ns5:DeferredTaxation2024-01-3100755431ns5:DeferredTaxation2024-02-012025-01-3100755431ns5:DeferredTaxation2025-01-31007554311ns10:Director12024-01-31007554311ns10:Director12023-01-31007554311ns10:Director12024-02-012025-01-31007554311ns10:Director12023-02-012024-01-31007554311ns10:Director12025-01-31007554311ns10:Director12024-01-31
REGISTERED NUMBER: 00755431 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 January 2025

for

Taylors Organex Limited

Taylors Organex Limited (Registered number: 00755431)






Contents of the Financial Statements
for the year ended 31 January 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Taylors Organex Limited

Company Information
for the year ended 31 January 2025







DIRECTORS: R M Taylor
Mrs P Taylor





SECRETARY: Mrs P Taylor





REGISTERED OFFICE: Unit 1
Alexandra Business Park
Gresty Lane
Crewe
Cheshire
CW2 5DD





REGISTERED NUMBER: 00755431 (England and Wales)





ACCOUNTANTS: Banks Sheridan
Datum House
Electra Way
Crewe
Cheshire
CW1 6ZF

Taylors Organex Limited (Registered number: 00755431)

Statement of Financial Position
31 January 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 5 1,957 -
Investments 6 100,000 153,958
Investment property 7 649,092 620,000
751,049 773,958

CURRENT ASSETS
Debtors 8 95,775 79,397
Cash at bank 13,510 7,782
109,285 87,179
CREDITORS
Amounts falling due within one year 9 (40,072 ) (27,871 )
NET CURRENT ASSETS 69,213 59,308
TOTAL ASSETS LESS CURRENT
LIABILITIES

820,262

833,266

CREDITORS
Amounts falling due after more than one
year

10

(194,000

)

(215,258

)

PROVISIONS FOR LIABILITIES 14 (103,878 ) (103,098 )
NET ASSETS 522,384 514,910

CAPITAL AND RESERVES
Called up share capital 2,000 2,000
Capital redemption reserve 600 600
Retained earnings 519,784 512,310
SHAREHOLDERS' FUNDS 522,384 514,910

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Taylors Organex Limited (Registered number: 00755431)

Statement of Financial Position - continued
31 January 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 May 2025 and were signed on its behalf by:





R M Taylor - Director


Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements
for the year ended 31 January 2025

1. STATUTORY INFORMATION

Taylors Organex Limited ('The Company') is a holding company.

The company is a private company limited by shares and is incorporated in England and Wales. The address of the principal place of business and of the registered office is Unit 1 Alexandra Business Park, Gresty Lane, Crewe, Cheshire, CW2 5DD. The registered number can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£). Monetary amounts in these financial statements are rounded to the nearest £.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below.

These policies have been consistently applied to all years presented, unless otherwise stated.

Basis of preparation
The financial statements are prepared on the going concern basis under the historical cost convention and comply with the United Kingdom Accounting Standards and Companies Act 2006.

Going concern
No material uncertainties that may cast significant doubt about the ability of the company to continue as a going concern have been identified by the directors.

Notwithstanding any uncertainties the directors consider it appropriate to prepare the financial statements on the going concern basis.

Turnover
Revenue (described as turnover) represents invoiced management charges, excluding value added tax.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and accumulated impairment losses plus any revaluations. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided at the following annual rates so as to write off their cost less residual amounts over their estimated useful economic lives. Assets are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognised for the amount by which the assets carrying amount exceeds its recoverable amount.

Fixtures and equipment- 25% on reducing balance

The residual values and useful lives of assets are reviewed and adjusted if appropriate at each reporting period end date.

Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements - continued
for the year ended 31 January 2025

3. ACCOUNTING POLICIES - continued

Investment property
Investment property is shown at fair value, the fair value is reviewed annually by the director. Any aggregate surplus or deficit arising from changes in the fair value in the year is recognised in the profit or loss within the Statement of Comprehensive Income. The cumulative fair value surplus on the investment property is highlighted in the notes to the financial statements as non-distributable reserves. Rentals are recognised on a straight line basis over the period of the lease or to the date of the next rent review. Net rental income after direct costs is included in other operating income. The company's freehold property has been treated as an investment property as of 31 January 2023.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the end of the financial year.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the end of the financial year.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Other income
Rentals are recognised on a straight line basis over the period of the lease or to the date of the next rent review. Rental income received is included in other operating income.

Impairment of assets
Assets not measured at fair value are reviewed for any indications that the asset may be impaired at each statement of financial position date. If such indications exists the recoverable amount of the asset or the assets cash generating unit is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

Any losses arising from impairment are recognised in the Statement of Comprehensive Income under the appropriate heading.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements - continued
for the year ended 31 January 2025

5. TANGIBLE FIXED ASSETS
Fixtures
and
equipment
£   
COST OR VALUATION
Additions 2,046
At 31 January 2025 2,046
DEPRECIATION
Charge for year 89
At 31 January 2025 89
NET BOOK VALUE
At 31 January 2025 1,957


6. FIXED ASSET INVESTMENTS
Unlisted
investments
£   
COST
At 1 February 2024 153,958
Disposals (53,958 )
At 31 January 2025 100,000
NET BOOK VALUE
At 31 January 2025 100,000
At 31 January 2024 153,958

The company's investments at the Statement of Financial Position date in the share capital of companies include the following:

Homefeeds Ltd
Registered office: Unit 1, Alexandra Business Park, Gresty Lane, Crewe, Cheshire, CW2 5DD
Nature of business: Sale of horticultural supplies
%
Class of shares: holding
Ordinary 100.00
2025 2024
£    £   
Aggregate capital and reserves 108,199 123,585
Profit for the year 28,664 12,831

Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements - continued
for the year ended 31 January 2025

7. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 February 2024 620,000
Additions 29,092
At 31 January 2025 649,092
NET BOOK VALUE
At 31 January 2025 649,092
At 31 January 2024 620,000

Investment property was valued on an open market basis on 17 January 2023 by Butters John Bee, an independent firm.

Fair value at 31 January 2025 is represented by:
£   
Valuation in 2023 620,000
Cost 29,092
649,092

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Amounts owed by group undertakings 86,064 76,824
Other debtors 9,711 2,573
95,775 79,397

Amounts owed by group undertakings and related parties are unsecured, interest free and repayable on demand.

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 11) 23,764 22,557
Trade creditors 703 764
Taxation and social security 12,424 746
Other creditors 3,181 3,804
40,072 27,871

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans (see note 11) 194,000 215,258

Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements - continued
for the year ended 31 January 2025

10. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
2025 2024
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more than 5 years 88,904 115,734

11. LOANS

An analysis of the maturity of loans is given below:

2025 2024
£    £   
Amounts falling due within one year or on demand:
Bank loans 23,764 22,557

Amounts falling due between one and two years:
Bank loans - 1-2 years 24,539 23,431

Amounts falling due between two and five years:
Bank loans - 2-5 years 80,557 76,093

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more than 5 years 88,904 115,734

12. LEASING AGREEMENTS
The company had outstanding commitments in respect of operating leases as at 31 January 2025 of £46,272 (2024: £7,315).

Minimum lease payments receivable fall due as follows:

Non-cancellable operating
leases
2025 2024
£ £
Within one year 43,850 27,000
Between one and five years 91,950 34,700
135,800 61,700

Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements - continued
for the year ended 31 January 2025

13. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£    £   
Bank loans 217,764 237,815

The bank loans and overdraft are secured by a debenture over the company's assets and cross-guarantee given by the company's subsidiary undertaking.

14. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 103,878 103,098

Deferred
tax
£   
Balance at 1 February 2024 103,098
Charge to Income Statement during year 780
Balance at 31 January 2025 103,878

15. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2025 and 31 January 2024:

2025 2024
£    £   
R M Taylor and Mrs P Taylor
Balance outstanding at start of year 77 -
Amounts advanced - 77
Amounts repaid (77 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 77

Taylors Organex Limited (Registered number: 00755431)

Notes to the Financial Statements - continued
for the year ended 31 January 2025

16. RELATED PARTY DISCLOSURES

Transactions with related parties during the year and balances outstanding at the end of the reporting period were as follows:

Entities over which the company has control:

2025 2024
£ £
Management fees receivable 48,000 34,200
Rent receivable 19,900 18,850
Utilities recharged 11,241 15,220
Dividends receivable 44,050 27,600
Amounts owed by entities 86,064 76,824


Entities in which the directors have an interest:

2025 2024
£ £
Rent receivable 3,360 12,700
Amounts due by entities 200 802

17. NON-DISTRIBUTABLE RESERVES

Included within retained earnings is an amount of £391,781 (2024: £391,781) which is non-distributable.